Redemption: 2023-03-15; Registration: 144A/Reg S; Comments: 02/17/2021 IQVIA Inc (IQV) EUR1.45bn 144A/Reg S sr notes 2-part. Ba3/BB (stable/stable). Via JPM (sole physical books, B&D)/Barc/BofA/GS/HSBC/WFS joint books, Citi, FITB, PNC, Mizuho, MUFG, TD, TSI, BBVA, BNPP, Huntington, RBC, Siebert Willliams as co-managers. No reg rights. List ISE. NY law. Settles 03/03 (T+10).
- EUR550m (from minimum EUR400m) due 03/15/26 (5y). NC2 (03/15/23) (MWC B+50bp), then at 100.875, 100.438, 100. Equity claw: 2y 40% at 101.75. Reg S ISIN: XS2305742434. IPT: 2.00%-2.25%. Px talk: 1.75%-1.875%. Final pricing: EUR550m at 1.75%. Priced: 1.75% at 100. +240bp vs DBR 0.5% 02/15/26.
- EUR900m due 03/15/29 (8y). NC3 (MWC B+50bp), then at 101.125, 100.563, 100. Equity claw: 3y 40% at 102.25. Reg S ISIN: XS2305744059. IPT: 2.50% area. Px talk: 2.25%-2.50%. Final pricing: EUR900m at 2.25%. Priced: 2.25% at 100. +273bp vs DBR 0.25% 02/5/29.
Did global investor call at 1pm UKT 02/16 (virtual 1x1 meetings were also available 02/16). Books closed at 2pm UKT 0217. UOP: redeem its EUR1.425bn 3.25% sr notes due 03/15/25 (callable at 100.813 on 03/15/21). Biz: leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. HQ: Durham, NC and Danbury, CT.;
Redemption: 2024-03-15; Registration: 144A/Reg S; Comments: 02/17/2021 IQVIA Inc (IQV) EUR1.45bn 144A/Reg S sr notes 2-part. Ba3/BB (stable/stable). Via JPM (sole physical books, B&D)/Barc/BofA/GS/HSBC/WFS joint books, Citi, FITB, PNC, Mizuho, MUFG, TD, TSI, BBVA, BNPP, Huntington, RBC, Siebert Willliams as co-managers. No reg rights. List ISE. NY law. Settles 03/03 (T+10).
- EUR550m (from minimum EUR400m) due 03/15/26 (5y). NC2 (03/15/23) (MWC B+50bp), then at 100.875, 100.438, 100. Equity claw: 2y 40% at 101.75. Reg S ISIN: XS2305742434. IPT: 2.00%-2.25%. Px talk: 1.75%-1.875%. Final pricing: EUR550m at 1.75%. Priced: 1.75% at 100. +240bp vs DBR 0.5% 02/15/26.
- EUR900m due 03/15/29 (8y). NC3 (MWC B+50bp), then at 101.125, 100.563, 100. Equity claw: 3y 40% at 102.25. Reg S ISIN: XS2305744059. IPT: 2.50% area. Px talk: 2.25%-2.50%. Final pricing: EUR900m at 2.25%. Priced: 2.25% at 100. +273bp vs DBR 0.25% 02/5/29.
Did global investor call at 1pm UKT 02/16 (virtual 1x1 meetings were also available 02/16). Books closed at 2pm UKT 0217. UOP: redeem its EUR1.425bn 3.25% sr notes due 03/15/25 (callable at 100.813 on 03/15/21). Biz: leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. HQ: Durham, NC and Danbury, CT.;
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.